Enlivex Therapeutics Ltd
(ENLV)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -4,126 | -2,665 | -4,242 | -2,657 | N/A |
| Depreciation Amortization | 95 | 44 | 121 | 82 | N/A |
| Accounts receivable | -318 | 549 | -423 | -100 | N/A |
| Accounts payable and accrued liabilities | 127 | 90 | 145 | 94 | N/A |
| Other Working Capital | -73 | 943 | 83 | 200 | N/A |
| Other Operating Activity | 951 | -30 | 1,155 | 272 | 0 |
| Operating Cash Flow | $-3,344 | $-1,069 | $-3,161 | $-2,109 | $N/A |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | -40 | -40 | N/A |
| PPE Investments | -132 | -78 | -461 | -180 | N/A |
| Sale Of Investment | 1,544 | 1,544 | N/A | N/A | N/A |
| Other Investing Activity | 0 | 0 | 0 | -33 | 0 |
| Investing Cash Flow | $1,412 | $1,466 | $-501 | $-253 | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 7,710 | 4,711 | 5,194 | 5,144 | N/A |
| Financing Cash Flow | $7,710 | $4,711 | $5,194 | $5,144 | $N/A |
| Exchange Rate Effect | 535 | 301 | -772 | -436 | N/A |
| Beginning Cash Position | 9,792 | 9,792 | 9,032 | 9,005 | N/A |
| End Cash Position | 16,105 | 15,201 | 9,792 | 11,351 | N/A |
| Net Cash Flow | $6,313 | $5,409 | $760 | $2,346 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,344 | -1,069 | -3,161 | -2,109 | N/A |
| Capital Expenditure | -132 | -78 | -461 | -180 | N/A |
| Free Cash Flow | -3,476 | -1,147 | -3,622 | -2,289 | 0 |